Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.
Pighi M, Tomai F, Petrolini A, de Luca L, Tarantini G, Barioli A, Colombo P, Klugmann S, Ferlini M, Ormezzano MF, Loi B, Calabrò P, Bianchi RM, Faggian G, Forni A, Vassanelli C, Valgimigli M, Ribichini F. Pighi M, et al. Among authors: calabro p. J Cardiovasc Transl Res. 2016 Feb;9(1):40-8. doi: 10.1007/s12265-015-9665-x. Epub 2015 Dec 18. J Cardiovasc Transl Res. 2016. PMID: 26684009 Clinical Trial.
Scientific foundation and possible implications for practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site andSystemic Implementation of AngioX (MATRIX) trial.
Valgimigli M, Calabrò P, Cortese B, Frigoli E, Garducci S, Rubartelli P, Andò G, Santarelli A, Galli M, Garbo R, Repetto A, Ierna S, Briguori C, Limbruno U, Violini R, Gagnor A; MATRIX investigators. Valgimigli M, et al. Among authors: calabro p. J Cardiovasc Transl Res. 2014 Feb;7(1):101-11. doi: 10.1007/s12265-013-9537-1. Epub 2014 Jan 7. J Cardiovasc Transl Res. 2014. PMID: 24395497 Clinical Trial.
Randomized comparison of operator radiation exposure comparing transradial and transfemoral approach for percutaneous coronary procedures: rationale and design of the minimizing adverse haemorrhagic events by TRansradial access site and systemic implementation of angioX - RAdiation Dose study (RAD-MATRIX).
Sciahbasi A, Calabrò P, Sarandrea A, Rigattieri S, Tomassini F, Sardella G, Zavalloni D, Cortese B, Limbruno U, Tebaldi M, Gagnor A, Rubartelli P, Zingarelli A, Valgimigli M. Sciahbasi A, et al. Among authors: calabro p. Cardiovasc Revasc Med. 2014 Jun;15(4):209-13. doi: 10.1016/j.carrev.2014.03.010. Epub 2014 Mar 26. Cardiovasc Revasc Med. 2014. PMID: 24746599 Clinical Trial.
Preoperative evaluation before MitraClip®: present and future perspective.
Salerno G, Schmidt FP, Bigazzi MC, Sordelli C, Bianchi R, Golino P, Calabrò P, Russo MG, Calabrò R, Pacileo G. Salerno G, et al. Among authors: calabro r, calabro p. Future Cardiol. 2014 Nov;10(6):725-44. doi: 10.2217/fca.14.53. Future Cardiol. 2014. PMID: 25495815 Review.
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.
Costa F, Vranckx P, Leonardi S, Moscarella E, Ando G, Calabro P, Oreto G, Zijlstra F, Valgimigli M. Costa F, et al. Among authors: calabro p. Eur Heart J. 2015 May 21;36(20):1242-51. doi: 10.1093/eurheartj/ehv038. Epub 2015 Feb 25. Eur Heart J. 2015. PMID: 25718355 Clinical Trial.
Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
Andò G, Cortese B, Frigoli E, Gagnor A, Garducci S, Briguori C, Rubartelli P, Calabrò P, Valgimigli M; MATRIX investigators. Andò G, et al. Among authors: calabro p. Catheter Cardiovasc Interv. 2015 Nov;86(5):950-7. doi: 10.1002/ccd.25932. Epub 2015 Apr 9. Catheter Cardiovasc Interv. 2015. PMID: 25854692 Clinical Trial.
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial.
Leonardi S, Frigoli E, Rothenbühler M, Navarese E, Calabró P, Bellotti P, Briguori C, Ferlini M, Cortese B, Lupi A, Lerna S, Zavallonito-Parenti D, Esposito G, Tresoldi S, Zingarelli A, Rigattieri S, Palmieri C, Liso A, Abate F, Zimarino M, Comeglio M, Gabrielli G, Chieffo A, Brugaletta S, Mauro C, Van Mieghem NM, Heg D, Jüni P, Windecker S, Valgimigli M; MATRIX Investigators. Leonardi S, et al. Among authors: calabro p. BMJ. 2016 Sep 27;354:i4935. doi: 10.1136/bmj.i4935. BMJ. 2016. PMID: 27677503 Free article.
Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry).
Cortese B, Ielasi A, Moscarella E, Loi B, Tarantini G, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Varricchio A, Tespili M, Latini RA, Defilippi G, Corrado D, Steffenino G; RAI Investigators. Cortese B, et al. Among authors: calabro p. Am J Cardiol. 2017 Jun 15;119(12):1924-1930. doi: 10.1016/j.amjcard.2017.03.017. Epub 2017 Mar 29. Am J Cardiol. 2017. PMID: 28438304 Clinical Trial.
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
Tarantini G, Mojoli M, Masiero G, Cortese B, Loi B, Varricchio A, Gabrielli G, Durante A, Pasquetto G, Calabrò P, Gistri R, Tumminello G, Misuraca L, Pisano F, Ielasi A, Mazzarotto P, Coscarelli S, Lucci V, Moretti L, Nicolino A, Colombo A, Olivari Z, Fineschi M, Piraino D, Piatti L, Canosi U, Tellaroli P, Corrado D, Rovera C, Steffenino G; all RAI investigators. Tarantini G, et al. Among authors: calabro p. Catheter Cardiovasc Interv. 2018 Jan 1;91(1):E1-E16. doi: 10.1002/ccd.27095. Epub 2017 May 13. Catheter Cardiovasc Interv. 2018. PMID: 28500737
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry.
De Luca L, Musumeci G, Leonardi S, Gonzini L, Cavallini C, Calabrò P, Mauro C, Cacciavillani L, Savonitto S, De Servi S; EYESHOT Investigators. De Luca L, et al. Among authors: calabro p. J Cardiovasc Med (Hagerstown). 2017 Aug;18(8):580-589. doi: 10.2459/JCM.0000000000000533. J Cardiovasc Med (Hagerstown). 2017. PMID: 28639987
491 results